CT guided interstitial high dose rate brachytherapy for recurrent malignant gliomas.
- 1 August 1999
- journal article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 72 (860), 805-808
- https://doi.org/10.1259/bjr.72.860.10624349
Abstract
This paper describes the technique and preliminary results of high dose rate (HDR) interstitial brachytherapy for recurrent grade III and grade IV gliomas. Although in the initial treatment of malignant gliomas brachytherapy has been shown to give better results than external beam therapy, this has previously always been with low dose rate (LDR) brachytherapy. Stereotactic frames are used for interstitial LDR brachytherapy but a CT image-guided technique does not require such a frame. The survival rates for our initial 53 patients do not significantly differ from LDR results. However, using HDR there are several advantages, including a much shorter treatment time with HDR than LDR and better patient comfort. HDR also allows better individualized optimization of the treatment than LDR.Keywords
This publication has 12 references indexed in Scilit:
- CT-based software for 3-D localization and reconstruction in stepping source brachytherapyIEEE Transactions on Information Technology in Biomedicine, 1997
- Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsJournal of Neuro-Oncology, 1992
- High activity iodine-125 interstitial implant for gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experienceInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final reportInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1989
- National survey of patterns of care for brain-tumor patientsJournal of Neurosurgery, 1989
- Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the scandinavian glioblastoma study groupCancer, 1981
- Assumptions in the radiotherapy of glioblastomaNeurology, 1980
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978